loader image
Saturday, November 15, 2025
67.2 F
McAllen
- Advertisement -

U.S. Reviewing if Moderna Shot Tied to Higher Heart Inflammation Risk in Young Adults

Translate to Spanish or other 102 languages!

Image for illustration only

By Celine Castronuovo – The Hill

- Advertisement -

Federal health officials are conducting an investigation into the effects of the Moderna COVID-19 vaccine following new research that showed it may be linked to a higher risk of heart inflammation in young adults than previously though, according to a report from The Washington Post.

Two people familiar with the review told the Post that the heart condition, called myocarditis, is likely still extremely rare, but added that the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are looking into new Canadian data suggesting a greater risk among a specific demographic that have received the Moderna vaccine. Read more, click here.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Former STHS Children’s Patient Launches His 10th Annual Holiday Toy Drive

Mega Doctor News “It’s better to give than to receive” may be a popular...

University of Houston & DHR Health Multi-Million Dollar Medical Research & Education Center in the RGV

The University of Houston and DHR Health Hospital System today announced an agreement to establish The University of Houston Tilman J. Fertitta Family College of Medicine and DHR Health Medical Research and Education Center in the Rio Grande Valley.

Minimally Invasive Procedure for Aortic Valve Disease Has Similar Outcomes as Surgery, Study Reports

Mega Doctor News People who underwent a minimally invasive procedure to have...

Misleading FDA Warnings on Hormone Replacement Therapy Removed

The U.S. Department of Health and Human Services (HHS) today announced historic action to restore gold-standard science to women’s health. After more than two decades of fear and misinformation surrounding hormone replacement therapy (HRT), the U.S. Food and Drug Administration (FDA) is initiating the removal of broad “black box” warnings from HRT products for menopause.
- Advertisement -
×